Literature DB >> 31363950

Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.

Melek Mutlu1, Ozge Sarac2, Nurullah Cağıl2, Gamze Avcıoğlu3.   

Abstract

PURPOSE: To analyze the relationship between the seasonal allergic conjunctivitis (SAC), eotaxin-2, matrix metalloproteinase-9 (MMP-9), and the topographical findings in the keratoconus patients.
METHODS: Thirty-four eyes of patients without SAC (Group 1), 34 eyes of patients with SAC (Group 2), and 20 eyes of control subjects (control group) were enrolled. Tear samples of the subjects were collected by Schirmer method. Corneal topography parameters, tear MMP-9, and tear eotaxin-2 levels were analyzed.
RESULTS: The mean tear MMP-9 levels in Groups 1 and 2 were significantly higher than in the control group (p = 0.004). MMP-9 level exhibited a positive correlation with the keratoconus stage and a negative correlation with the thinnest corneal thickness (r = 0.294, p = 0.018, and r = - 0.302, p = 0.006, respectively). The tear eotaxin-2 level was higher in Group 2 than in Group 1 and control group which is not statistically significant (p = 0.17).
CONCLUSION: The tear eotaxin-2 did not exhibit any difference in the presence of keratoconus. The tear MMP-9 level was higher in the keratoconic eyes, and it showed a correlation with the stage of the disease and the corneal thickness.

Entities:  

Keywords:  Corneal topography; Eotaxin-2; Keratoconus; MMP-9; Seasonal allergic conjunctivitis

Mesh:

Substances:

Year:  2019        PMID: 31363950     DOI: 10.1007/s10792-019-01149-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  34 in total

1.  Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A.

Authors:  Rohit Shetty; Anuprita Ghosh; Rayne R Lim; Murali Subramani; Krina Mihir; A R Reshma; Ashwini Ranganath; Sriharsha Nagaraj; Rudy M M A Nuijts; Roger Beuerman; Reshma Shetty; Debashish Das; Shyam S Chaurasia; Abhijit Sinha-Roy; Arkasubhra Ghosh
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-03       Impact factor: 4.799

2.  Effect of Allergic Diseases on Keratoconus Severity.

Authors:  Mohammad Naderan; Mohammad Taher Rajabi; Parviz Zarrinbakhsh; Anahita Bakhshi
Journal:  Ocul Immunol Inflamm       Date:  2016-03-25       Impact factor: 3.070

3.  Inflammatory molecules in the tears of patients with keratoconus.

Authors:  Isabel Lema; Juan A Durán
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

4.  Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology.

Authors:  S D Trocmé; C K Hallberg; K S Gill; G J Gleich; S K Tyring; M M Brysk
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-03       Impact factor: 4.799

5.  Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.

Authors:  Merih Oray; Ebru Toker
Journal:  Cornea       Date:  2013-08       Impact factor: 2.651

6.  Evaluation of the corneal topographic characteristics of keratoconus with orbscan II in patients with and without atopy.

Authors:  Vedat Kaya; Muharrem Karakaya; Canan Asli Utine; Sinan Albayrak; Omer Faruk Oge; Omer Faruk Yilmaz
Journal:  Cornea       Date:  2007-09       Impact factor: 2.651

7.  Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis.

Authors:  Simone Eperon; Alain Sauty; René Lanz; Annette Leimgruber; Floriana Lurati; Yan Guex-Crosier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-25       Impact factor: 3.117

8.  Keratoconus Progression in Patients With Allergy and Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test.

Authors:  Cosimo Mazzotta; Claudio Traversi; Pierfrancesco Mellace; Simone A Bagaglia; Silvio Zuccarini; Rita Mencucci; Soosan Jacob
Journal:  Eye Contact Lens       Date:  2018-11       Impact factor: 2.018

9.  Association between mediators in the tear fluid and the severity of keratoconus.

Authors:  Bence Lajos Kolozsvári; Goran Petrovski; Péter Gogolák; Éva Rajnavölgyi; Flóra Tóth; András Berta; Mariann Fodor
Journal:  Ophthalmic Res       Date:  2013-11-14       Impact factor: 2.892

10.  Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.

Authors:  U Forssmann; M Uguccioni; P Loetscher; C A Dahinden; H Langen; M Thelen; M Baggiolini
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

View more
  1 in total

1.  Keratoconus patients exhibit a distinct ocular surface immune cell and inflammatory profile.

Authors:  Sharon D'Souza; Archana Padmanabhan Nair; Ganesh Ram Sahu; Tanuja Vaidya; Rohit Shetty; Pooja Khamar; Ritika Mullick; Sneha Gupta; Mor M Dickman; Rudy M M A Nuijts; Rajiv R Mohan; Arkasubhra Ghosh; Swaminathan Sethu
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.